USD 1.21
(-6.92%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 25.03 Million USD | 266.99% |
2022 | 6.82 Million USD | 128.31% |
2021 | 2.98 Million USD | -8.54% |
2020 | 3.26 Million USD | -64.96% |
2019 | 9.32 Million USD | 22.72% |
2018 | 7.59 Million USD | 14.86% |
2017 | 6.61 Million USD | 16.83% |
2016 | 5.66 Million USD | -29.07% |
2015 | 7.98 Million USD | -5.55% |
2014 | 8.45 Million USD | -61.4% |
2013 | 21.89 Million USD | 98.38% |
2012 | 11.03 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 25.07 Million USD | 0.17% |
2024 Q2 | 24.4 Million USD | -2.7% |
2023 Q1 | 6.21 Million USD | -8.94% |
2023 Q3 | 27.11 Million USD | -0.37% |
2023 Q2 | 27.21 Million USD | 338.07% |
2023 Q4 | 25.03 Million USD | -7.66% |
2023 FY | 25.03 Million USD | 266.99% |
2022 Q2 | 11.23 Million USD | 0.67% |
2022 Q4 | 6.82 Million USD | 20.49% |
2022 FY | 6.82 Million USD | 128.31% |
2022 Q1 | 11.15 Million USD | 273.43% |
2022 Q3 | 5.66 Million USD | -49.59% |
2021 Q4 | 2.98 Million USD | -25.69% |
2021 Q3 | 4.02 Million USD | 5.48% |
2021 Q2 | 3.81 Million USD | -46.6% |
2021 FY | 2.98 Million USD | -8.54% |
2021 Q1 | 7.13 Million USD | 39.11% |
2020 Q3 | 2.98 Million USD | 9.48% |
2020 FY | 3.26 Million USD | -64.96% |
2020 Q1 | 5.22 Million USD | -43.99% |
2020 Q4 | 5.13 Million USD | 72.21% |
2020 Q2 | 2.72 Million USD | -47.87% |
2019 Q3 | 9.61 Million USD | -6.91% |
2019 FY | 9.32 Million USD | 22.72% |
2019 Q4 | 9.32 Million USD | -3.0% |
2019 Q2 | 10.32 Million USD | 3.05% |
2019 Q1 | 10.01 Million USD | 31.86% |
2018 Q4 | 7.59 Million USD | 0.93% |
2018 FY | 7.59 Million USD | 14.86% |
2018 Q2 | 7.07 Million USD | 2.87% |
2018 Q1 | 6.87 Million USD | 3.95% |
2018 Q3 | 7.52 Million USD | 6.43% |
2017 Q2 | 5.46 Million USD | -5.09% |
2017 Q3 | 6.1 Million USD | 11.8% |
2017 Q4 | 6.61 Million USD | 8.28% |
2017 FY | 6.61 Million USD | 16.83% |
2017 Q1 | 5.75 Million USD | 1.68% |
2016 FY | 5.66 Million USD | -29.07% |
2016 Q4 | 5.66 Million USD | -0.07% |
2016 Q3 | 5.66 Million USD | -6.07% |
2016 Q2 | 6.03 Million USD | -8.92% |
2016 Q1 | 6.62 Million USD | -17.03% |
2015 Q4 | 7.98 Million USD | -9.12% |
2015 Q2 | 8.84 Million USD | -1.75% |
2015 Q1 | 8.99 Million USD | 6.47% |
2015 Q3 | 8.78 Million USD | -0.65% |
2015 FY | 7.98 Million USD | -5.55% |
2014 Q2 | 26.57 Million USD | 10.33% |
2014 FY | 8.45 Million USD | -61.4% |
2014 Q4 | 8.45 Million USD | -70.94% |
2014 Q3 | 29.08 Million USD | 9.43% |
2014 Q1 | 24.09 Million USD | 10.03% |
2013 FY | 21.89 Million USD | 98.38% |
2013 Q4 | 21.89 Million USD | 0.0% |
2012 FY | 11.03 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Acutus Medical, Inc. | 54.83 Million USD | 54.346% |
Axonics, Inc. | 82.35 Million USD | 69.601% |
INVO Bioscience, Inc. | 19.99 Million USD | -25.212% |
CVRx, Inc. | 39.28 Million USD | 36.266% |
iRhythm Technologies, Inc. | 223.04 Million USD | 88.775% |
Monogram Orthopaedics, Inc. | 3.18 Million USD | -686.815% |
MaxCyte, Inc. | 36.1 Million USD | 30.662% |
ClearPoint Neuro, Inc. | 21.48 Million USD | -16.512% |
PROCEPT BioRobotics Corporation | 123.96 Million USD | 79.804% |
Sintx Technologies, Inc. | 6.59 Million USD | -279.736% |
Accelerate Diagnostics, Inc. | 51.25 Million USD | 51.153% |
Apyx Medical Corporation | 52.31 Million USD | 52.146% |
Cutera, Inc. | 518.12 Million USD | 95.168% |
Helius Medical Technologies, Inc. | 5.34 Million USD | -368.663% |
NeuroPace, Inc. | 86.99 Million USD | 71.222% |
IRIDEX Corporation | 24.91 Million USD | -0.49% |
Tactile Systems Technology, Inc. | 87.79 Million USD | 71.484% |
enVVeno Medical Corporation | 2.43 Million USD | -928.172% |
TELA Bio, Inc. | 59.16 Million USD | 57.686% |
Tandem Diabetes Care, Inc. | 639.02 Million USD | 96.082% |
UFP Technologies, Inc. | 118.04 Million USD | 78.791% |
Modular Medical, Inc. | 2.27 Million USD | -1001.937% |
STRATA Skin Sciences, Inc. | 29.32 Million USD | 14.634% |
LENSAR, Inc. | 22.4 Million USD | -11.723% |
Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.859% |
Surmodics, Inc. | 65.82 Million USD | 61.965% |
Vivos Therapeutics, Inc. | 10.31 Million USD | -142.62% |
Inogen, Inc. | 121.38 Million USD | 79.374% |
Tivic Health Systems, Inc. | 1.67 Million USD | -1395.579% |
RxSight, Inc. | 22.18 Million USD | -12.836% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -5786.931% |
Lucid Diagnostics Inc. | 29.58 Million USD | 15.365% |
Nano-X Imaging Ltd. | 23.13 Million USD | -8.222% |
Nexalin Technology, Inc. | 425.28 Thousand USD | -5786.931% |
PetVivo Holdings, Inc. | 2.42 Million USD | -930.585% |
Cytek Biosciences, Inc. | 104.6 Million USD | 76.066% |
Alphatec Holdings, Inc. | 703.48 Million USD | 96.441% |
Rapid Micro Biosystems, Inc. | 25.46 Million USD | 1.677% |
Dynatronics Corporation | 11.78 Million USD | -112.528% |
TriSalus Life Sciences, Inc. | 51.66 Million USD | 51.54% |
InMode Ltd. | 75.91 Million USD | 67.021% |
Bruker Corporation | 2.83 Billion USD | 99.117% |
Movano Inc. | 5.97 Million USD | -319.223% |
Orthofix Medical Inc. | 326.58 Million USD | 92.334% |
FONAR Corporation | 57.45 Million USD | 56.427% |
BioSig Technologies, Inc. | 4.68 Million USD | -434.386% |
Envoy Medical, Inc. | 9.4 Million USD | -166.284% |
Align Technology, Inc. | 2.45 Billion USD | 98.98% |
Anika Therapeutics, Inc. | 58.36 Million USD | 57.106% |
Talis Biomedical Corporation | 29.22 Million USD | 14.331% |
Cerus Corporation | 144.3 Million USD | 82.651% |
908 Devices Inc. | 37.49 Million USD | 33.22% |
Nemaura Medical Inc. | 26.37 Million USD | 5.086% |
Outset Medical, Inc. | 190.91 Million USD | 86.886% |
NanoVibronix, Inc. | 2.68 Million USD | -832.092% |
Venus Concept Inc. | 107.1 Million USD | 76.624% |
Telesis Bio, Inc. | 40.87 Million USD | 38.747% |
Treace Medical Concepts, Inc. | 113.96 Million USD | 78.033% |
Quipt Home Medical Corp. | 136.29 Million USD | 81.631% |
IRadimed Corporation | 20.73 Million USD | -20.737% |
Tenon Medical, Inc. | 5.56 Million USD | -349.722% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -600.896% |
Pulmonx Corporation | 60.63 Million USD | 58.711% |
iCAD, Inc. | 8 Million USD | -212.911% |
QT Imaging Holdings, Inc. | 12.69 Million USD | -97.282% |
NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1254.828% |
Viemed Healthcare, Inc. | 40.79 Million USD | 38.623% |
SI-BONE, Inc. | 61.05 Million USD | 58.991% |
Semler Scientific, Inc. | 6.27 Million USD | -299.298% |
Biotricity, Inc. | 35.91 Million USD | 30.3% |
Cytosorbents Corporation | 29.98 Million USD | 16.506% |
DexCom, Inc. | 4.19 Billion USD | 99.403% |
ZimVie Inc. | 795.85 Million USD | 96.854% |
Aethlon Medical, Inc. | 2.47 Million USD | -909.659% |
DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -109.365% |
IceCure Medical Ltd | 4.24 Million USD | -489.498% |
PAVmed Inc | 57.13 Million USD | 56.183% |
Sight Sciences, Inc. | 46.43 Million USD | 46.085% |
Insulet Corporation | 1.85 Billion USD | 98.651% |
Profound Medical Corp. | 12.66 Million USD | -97.665% |
electroCore, Inc. | 8.94 Million USD | -179.888% |
Bioventus Inc. | 589.79 Million USD | 95.755% |
InspireMD, Inc. | 8.14 Million USD | -207.492% |
PAVmed Inc. | 57.13 Million USD | 56.183% |
Nuwellis, Inc. | 6.78 Million USD | -269.263% |
OrthoPediatrics Corp. | 72.56 Million USD | 65.497% |
DIH Holding US, Inc. Warrants | 11.95 Million USD | -109.365% |
BrainsWay Ltd. | 15.31 Million USD | -63.484% |
BIOLASE, Inc. | 35.34 Million USD | 29.173% |
Beyond Air, Inc. | 29.77 Million USD | 15.916% |
AxoGen, Inc. | 101.16 Million USD | 75.252% |
Inari Medical, Inc. | 209.32 Million USD | 88.04% |
Heart Test Laboratories, Inc. | 2.18 Million USD | -1045.387% |
Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1307.307% |
AdaptHealth Corp. | 3.15 Billion USD | 99.206% |
Quanterix Corporation | 78.08 Million USD | 67.937% |
Viveve Medical, Inc. | 10.84 Million USD | -130.81% |
LivaNova PLC | 1.15 Billion USD | 97.827% |
Co-Diagnostics, Inc. | 17.63 Million USD | -41.975% |
Varex Imaging Corporation | 668.6 Million USD | 96.255% |
ReShape Lifesciences Inc. | 4.06 Million USD | -516.043% |
Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -600.896% |
Sensus Healthcare, Inc. | 4.88 Million USD | -412.508% |
Pacific Biosciences of California, Inc. | 1.04 Billion USD | 97.604% |
TransMedics Group, Inc. | 568.84 Million USD | 95.599% |
ReWalk Robotics Ltd. | 16.68 Million USD | -50.078% |
NeuroMetrix, Inc. | 1.33 Million USD | -1777.995% |
Spectral AI, Inc. | 12.4 Million USD | -101.887% |
Hyperfine, Inc. | 9.8 Million USD | -155.469% |
Establishment Labs Holdings Inc. | 250.24 Million USD | 89.995% |
Biomerica, Inc. | 2.66 Million USD | -840.143% |
Bone Biologics Corporation | 831.4 Thousand USD | -2911.299% |
AVITA Medical, Inc. | 19.86 Million USD | -26.028% |
Bluejay Diagnostics, Inc. | 1.97 Million USD | -1168.491% |
Silk Road Medical, Inc | 114.15 Million USD | 78.069% |